Explorer les evidences

75 %Using a cut-off value of 0.45, the sensitivity of squamous cell carcinoma antigen was 75%.

Nigeriacancer du col de l'utéruspublié 2025European journal of medical researchPubMeddocument de 8 observations

30,1 per_100_women_yearsThe mortality rate for cervical cancer was 30.1 per 100 women-years.

Nigeriacancer du col de l'utérusobservé 2015–2021publié 2025International healthPubMeddocument de 2 observations

12 %Post-intervention, knowledge of cervical cancer symptoms increased to 12.0% in the control group.

Nigeriacancer du col de l'utéruspublié 2022West African journal of medicinePubMeddocument de 12 observations

0,3 %One respondent (0.3%) had been screened with visual inspection with acetic acid.

Nigeriacancer du col de l'utéruspublié 2021JCO global oncologyPubMeddocument de 7 observations

7 093 deaths_per_yearEach year, an average of 7093 women in Nigeria die from cervical cancer.

Nigeriacancer du col de l'utéruspublié 2025JMIR cancerPubMeddocument de 8 observations

Cervical cancer is the second most common cancer among women worldwide.

Nigeriacancer du col de l'utéruspublié 2021Journal of preventive medicine and hygienePubMeddocument de 11 observations

96,2 %Among 400 female students in tertiary institutions in Imo State, 385 (96.2%) knew that Human Papillomavirus (HPV) is the causative agent of cervical cancer.

Nigeriacancer du col de l'utérus · human papillomavirus (HPV)publié 2021Journal of community healthPubMeddocument de 9 observations

49 womenAmong the women screened, 49 (<1%) received both VIA and HPV DNA testing at the same time.

Nigeriacancer du col de l'utérusobservé 2021publié 2023BMC public healthPubMeddocument de 12 observations

3,6 aORIn the presence of high-risk HPV, community state type IV (CST-IV) was associated with high-grade squamous intraepithelial lesion or invasive cervical cancer with an adjusted odds ratio of 3.6.

Nigeriacancer du col de l'utérus · high-grade squamous intraepithelial lesion · high-risk human papillomavirusobservé 2020–2022publié 2023BMC cancerPubMeddocument de 14 observations

23,3 %23.3% of rural women in North Central Nigeria cited lack of knowledge about the test as a barrier to cervical cancer screening.

Nigeriacancer du col de l'utéruspublié 2026Rural and remote healthPubMeddocument de 21 observations

2 %About 2% of women screened for cervical cancer at Jos University Teaching Hospital in Nigeria were women living with HIV.

Nigeriacancer du col de l'utérus · VIH/sidapublié 2024Cancer causes & control : CCCPubMeddocument de 5 observations

7 %VIA positivity was 7% among women living with HIV in Nigeria.

Nigeriacancer du col de l'utérusAfrica CDCdocument de 52 observations

10,1 %Post-intervention, knowledge of cervical cancer symptoms increased from 10.1% to 66.5% in the intervention group.

Nigeriacancer du col de l'utéruspublié 2022West African journal of medicinePubMeddocument de 12 observations

84,5 %The primary case finder screening negative predictive value was 84.5% using gynaecologist review as confirmatory test.

Nigeriacancer du col de l'utérusobservé October 2020 to July 2021publié 2023Reproductive healthPubMeddocument de 9 observations

90,3 %90.3% of women in Taraba, North-East Nigeria had appropriate knowledge about the prevention of cervical cancer.

Nigeriacancer du col de l'utéruspublié 2019Asian Pacific journal of cancer prevention : APJCPPubMeddocument de 6 observations

66,05 %Knowledge of HPV and cervical cancer among junior secondary school aged girls had a mean score of 66.05%.

Nigeriacancer du col de l'utérus · infection à HPVpublié 2022BMC public healthPubMeddocument de 6 observations

604 000 casesGlobally, cervical cancer accounts for 604,000 new cases annually.

Nigeriacancer du col de l'utéruspublié 2025European journal of medical researchPubMeddocument de 8 observations

1,1 %Four respondents (1.1%) had taken the human papillomavirus vaccine before.

Nigeriacancer du col de l'utéruspublié 2021JCO global oncologyPubMeddocument de 7 observations

70,3 %70.3% of HIV-positive women had high-grade squamous intraepithelial lesion or invasive cervical cancer (HSIL/ICC).

Nigeriacancer du col de l'utérus · high-grade squamous intraepithelial lesion · VIH/sidaobservé 2020–2022publié 2023BMC cancerPubMeddocument de 14 observations

79,2 %79.2% of the respondents were willing to vaccinate their adolescent daughters against HPV.

Nigeriacancer du col de l'utéruspublié 2020The Pan African medical journalPubMeddocument de 5 observations

51 %The high-risk HPV detection rate was 51% among 101 cervical carcinoma cases.

Nigeriacancer du col de l'utérusobservé 2012–2016publié 2024The Pan African medical journalPubMeddocument de 5 observations

6,13 nmol/lThe mean serum malondialdehyde level was 6.13 ± 4.1 nmol/l among women with histologically confirmed cervical cancer.

Nigeriacancer du col de l'utéruspublié 2024West African journal of medicinePubMeddocument de 4 observations

15 %Cervical cancer screening rates were below 15% in Nigeria.

Nigeriacancer du col de l'utéruspublié 2026BMC public healthPubMeddocument de 3 observations

52,8 %52.8% of the 231 women received information about cervical cancer screening from friends.

Nigeriacancer du col de l'utéruspublié 2021Cancer treatment and research communicationsPubMeddocument de 11 observations

36 %36% of rural women in North Central Nigeria expressed willingness to undergo cervical cancer screening.

Nigeriacancer du col de l'utéruspublié 2026Rural and remote healthPubMeddocument de 21 observations